News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Two More Australian Biotechs To List On ASX
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Two Australian biotech companies lodged IPO prospectuses with ASIC this week, both looking to list in the next couple of months.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
IPO
2026 IPO stock tracker: How newly public biotechs are performing
September 9, 2026
·
1 min read
·
Gabrielle Masson
IPO
Steady stream of crossover rounds stock biotech’s IPO pipeline
September 9, 2026
·
7 min read
·
Annalee Armstrong
Deals
Biotech is back, with H1 progress smoothing glide path through end of year: Truist
September 4, 2026
·
3 min read
·
Annalee Armstrong
Antibody-drug conjugate (ADC)
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
September 4, 2026
·
2 min read
·
Tristan Manalac
